| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2001;103:743.)
© 2001 American Heart Association, Inc.
Basic Science Reports |
(TNF-
) Plays a Protective Role in Acute Viral Myocarditis in Mice
From the Department of Laboratory Medicine (H.W., K. Saito, H. Fujii, S.F., N.M., M.S.) and Second Department of Internal Medicine (H.T., H. Fujiwara), Gifu University School of Medicine, Gifu; Department of Laboratory Medicine, Gunma University School of Medicine, Gunma (T.K., I.K.); and Department of Immunology, National Institute of Animal Health (K. Sekikawa), Japan.
Correspondence to Hisayasu Wada, MD, PhD, Department of Laboratory Medicine, Gifu University School of Medicine, 40 Tsukasa-machi, Gifu 500-8705, Japan. E-mail wadah{at}cc.gifu-u.ac.jp
BackgroundIt
has been reported that tumor necrosis factor-
(TNF-
) is expressed
in the heart with viral myocarditis and that its expression aggravates
the condition. The pathophysiological effects of TNF-
on viral
myocarditis, however, have not been fully
elucidated.
Methods and ResultsTo
investigate the role of TNF-
in the progression of viral
myocarditis, we used TNF-
genedeficient mice
(TNF-
-/-) and induced acute
myocarditis by infection with encephalomyocarditis virus (EMCV). The
survival rate of TNF-
-/- mice after
EMCV infection was significantly lower than that of
TNF-
+/+ mice (0% versus 67% on day 14).
Injection of recombinant human TNF-
(0.2 to 4.0 µg/mouse IV)
improved the survival of TNF-
-/- mice
in a dose-dependent manner, indicating that TNF-
is essential for
protection against viral myocarditis. The levels of viral titer and
viral genomic RNA of EMCV in the myocardium were significantly higher
in TNF-
-/- than in
TNF-
+/+ mice. Histopathological
examination showed that the inflammatory changes of the myocardium were
less marked in TNF-
-/- than in
TNF-
+/+ mice. Immunohistochemical
analysis revealed that the levels of immunoreactivity of intercellular
adhesion molecule-1 and vascular cell adhesion molecule-1 in the
myocardium were decreased in TNF-
-/-
mice compared with TNF-
+/+
mice.
ConclusionsThese
observations suggested that TNF-
is necessary for adhesion molecule
expression and to recruit leukocytes to inflammatory sites, and thus,
the lack of this cytokine resulted in failure of elimination of
infectious agents. We concluded that TNF-
plays a protective role in
the acute stage of viral
myocarditis.
Key Words: tumor necrosis factor-
myocarditis viruses cell adhesion molecules
This article has been cited by other articles:
![]() |
K. A. Binymin Comment on: Adult-onset Still's disease and myocarditis: successful treatment with intravenous immunoglobulin and maintenance of remission with etanercept Rheumatology, November 1, 2007; 46(11): 1741 - 1742. [Full Text] [PDF] |
||||
![]() |
E. A. Jankowska, P. Ponikowski, M. F. Piepoli, W. Banasiak, S. D. Anker, and P. A. Poole-Wilson Autonomic imbalance and immune activation in chronic heart failure - Pathophysiological links Cardiovasc Res, June 1, 2006; 70(3): 434 - 445. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Li, D. Georgakopoulos, G. Lu, L. Hester, D. A. Kass, J. Hasday, and Y. Wang p38 MAP Kinase Mediates Inflammatory Cytokine Induction in Cardiomyocytes and Extracellular Matrix Remodeling in Heart Circulation, May 17, 2005; 111(19): 2494 - 2502. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Huber and D. Sartini Roles of Tumor Necrosis Factor Alpha (TNF-{alpha}) and the p55 TNF Receptor in CD1d Induction and Coxsackievirus B3-Induced Myocarditis J. Virol., March 1, 2005; 79(5): 2659 - 2665. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Guilherme, P. Cury, L. M.F. Demarchi, V. Coelho, L. Abel, A. P. Lopez, S. E. Oshiro, S. Aliotti, E. Cunha-Neto, P. M.A. Pomerantzeff, et al. Rheumatic Heart Disease: Proinflammatory Cytokines Play a Role in the Progression and Maintenance of Valvular Lesions Am. J. Pathol., November 1, 2004; 165(5): 1583 - 1591. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. CHEN, Q. KE, Y. YANG, J. S. RANA, J. TANG, J. P. MORGAN, and Y.-F. XIAO Cardiomyocytes overexpressing TNF-{alpha} attract migration of embryonic stem cells via activation of p38 and c-Jun amino-terminal kinase FASEB J, December 1, 2003; 17(15): 2231 - 2239. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Martire, B. Fernandez, A. Buehler, C. Strohm, J. Schaper, R. Zimmermann, P. E Kolattukudy, and W. Schaper Cardiac overexpression of monocyte chemoattractant protein-1 in transgenic mice mimics ischemic preconditioning through SAPK/JNK1/2 activation Cardiovasc Res, February 1, 2003; 57(2): 523 - 534. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Liu, P. Lee, K. Fuse, and M. Nian Molecular pathophysiological mechanisms in virus infected host myocardium Eur. Heart J. Suppl., December 1, 2002; 4(suppl_I): I37 - I41. [Abstract] [PDF] |
||||
![]() |
R. M Smith, S. Lecour, and M. N Sack Innate immunity and cardiac preconditioning: a putative intrinsic cardioprotective program Cardiovasc Res, August 15, 2002; 55(3): 474 - 482. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M Smith, N. Suleman, J. McCarthy, and M. N Sack Classic ischemic but not pharmacologic preconditioning is abrogated following genetic ablation of the TNF{alpha} gene Cardiovasc Res, August 15, 2002; 55(3): 553 - 560. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Knuefermann, S. Nemoto, G. Baumgarten, A. Misra, N. Sivasubramanian, B. A. Carabello, and J. G. Vallejo Cardiac Inflammation and Innate Immunity in Septic Shock* : Is There a Role for Toll-Like Receptors? Chest, April 1, 2002; 121(4): 1329 - 1336. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Scheubel, B. Bartling, A. Simm, R.-E. Silber, K. Drogaris, D. Darmer, and J. Holtz Apoptotic pathway activation from mitochondria and death receptors without caspase-3 cleavage in failing human myocardium: Fragile balance of myocyte survival? J. Am. Coll. Cardiol., February 6, 2002; 39(3): 481 - 488. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. L. Mann Tumor Necrosis Factor and Viral Myocarditis: The Fine Line Between Innate and Inappropriate Immune Responses in the Heart Circulation, February 6, 2001; 103(5): 626 - 629. [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2001 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |